Myoblast Differentiation via Segmented Culture Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating skeletal muscle in vitro are complex and costly, making it difficult to reproduce the process of muscle differentiation for therapeutic and research purposes, particularly for studying disease conditions, screening therapeutic agents, and preparing transplantable tissue.
Innovation Solution
A method involving a multi-step culture medium system comprising fetal bovine serum, chick embryo extract, and specific growth factors such as EGF, insulin, and ROCK inhibitors is used to differentiate pluripotent cells into myoblasts and subsequently into myotubes, optimizing the differentiation process by reducing experimental variation and differentiation time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If complex in vitro systems with multiple growth factors are used to differentiate skeletal muscle, then differentiation quality is improved, but process complexity and cost increase
Solution Approach 1:
The differentiation process is divided into distinct sequential stages: Stage 1 uses medium A with specific factors (BMP4, IGF-1, FGF2) to generate myoblast precursors, while Stage 2 uses medium B with different factors (EGF, insulin, HGF, FGF2) to mature myoblasts into myotubes. This segmentation allows optimization of each stage independently, improving overall differentiation quality while making the complex process more manageable and reproducible.
Solution Approach 2:
The invention specifies precise concentration ranges for each growth factor in each medium stage (e.g., BMP4 at 5-20 ng/mL in Stage 1, EGF at 10-50 ng/mL in Stage 2). By controlling and optimizing these parameters systematically, the method achieves high differentiation quality with reduced experimental variation, resolving the contradiction between quality and complexity.
2Productivity
If multiple growth factors and serum components are used in culture medium, then cell differentiation efficiency is improved, but production cost increases
Solution Approach 1:
The culture process is segmented into two stages with different medium compositions. Stage 1 medium contains BMP4, IGF-1, and FGF2 for precursor generation, while Stage 2 medium contains EGF, insulin, HGF, and FGF2 for maturation. This segmentation allows cost-effective production by using the minimum necessary factors at each stage rather than all factors throughout, improving differentiation efficiency while controlling costs.
Solution Approach 2:
Stage 1 performs preliminary differentiation to generate myoblast precursors using a specific factor组合, preparing the cells for the second stage. This preliminary action ensures that cells are properly primed before exposure to Stage 2 factors, improving overall differentiation efficiency and reducing the need for higher concentrations of expensive factors in Stage 2, thereby controlling production costs.
3Reliability
If traditional muscle differentiation methods are used, then basic myotube formation is achieved, but differentiation time is extended
Solution Approach 1:
The differentiation process uses periodic medium changes between Stage 1 and Stage 2, with defined transition timing. Cells are exposed to Stage 1 medium for a specific duration to generate precursors, then switched to Stage 2 medium for maturation. This periodic action with optimized timing accelerates the overall process while ensuring reliable myotube formation, reducing differentiation time without sacrificing quality.
Solution Approach 2:
The invention optimizes the concentration parameters of growth factors in each stage to accelerate differentiation kinetics. Stage 2 medium contains EGF at 10-50 ng/mL and insulin at 1-10 μg/mL, which are shown to accelerate myoblast maturation. By carefully controlling these parameters, the method achieves reliable myotube formation in reduced time compared to traditional single-stage methods.
Data Source
AI summary
Provided herein are methods and compositions for differentiating pluripotent cells, In embodiments, pluripotent cells are differentiated to form myoblast precursor cells, In embodiments, myoblast precursor cells are differentiated to form myoblasts. In embodiments, myoblasts are cultured to form myotubes. Media for culturing cells, cell products, and uses thereof are also described herein.